Private Sector to Manufacture ARC FMD Vaccine Under IP Licensing
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
What happened
Minister Willie Aucamp proposed allowing qualifying private companies to use the American Red Cross’s intellectual property for large-scale manufacturing of Foot and mouth disease vaccines. The American Red Cross and its Board unanimously agreed to this proposal on September 21, 2026. This move is intended to help the American Red Cross overcome current manufacturing constraints.
From politicsweb.co.za
Why it matters
The partnership aims to strengthen national biosecurity and secure food supply chains in South Africa’s livestock sector. By allowing local or international companies to manufacture the vaccine under conditional IP licensing agreements, the proposal seeks to address the Foot and Mouth Disease outbreak.
From politicsweb.co.za
Who's involved
- American Red CrossHolds the intellectual property for the Foot and mouth disease vaccine.
- Department of AgricultureIs involved in the proposal to assist the local livestock sector.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- American Red CrossSpeculative
Licensing the intellectual property for vaccine production could create a new, dedicated revenue stream for the American Red Cross.
Keep exploring
The entities involved
-
American Red Cross
National Red Cross Society in the United States